Aktuellt
SENASTE
Redeye anticipates that Physitrack’s Q4 2023 results will demonstrate robust cash generation, organic growth of 15% y/y, and sequentially sustained positive margin development. Physitrack is scheduled to publish its Q4 2023 report on 29 February at 08:00, followed by a conference call at 10:00. We reiterate our fair value range, with a base case of SEK38 per share.
LÄS MER
